<scp>OnabotulinumtoxinA</scp> treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine <scp>OnabotulinuMtoxinA</scp> Prolonged Efficacy open‐Label ( <scp>COMPEL</scp> ) trial

Andrew M. Blumenfeld, Larry Charleston, Deena Kuruvilla, Belinda Savage‐Edwards, Richard B. Lipton, Ritu Singh, Patricia Jacob, Nicole A. Lawrence, Cuiwei Wang, Hope L. O'Brien

Open source

DOI: 10.1111/head.70007
Published: 2025-12-15
Container: Headache: The Journal of Head and Face Pain
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/head.70007,
  title = {<scp>OnabotulinumtoxinA</scp>
                    treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine
                    <scp>OnabotulinuMtoxinA</scp>
                    Prolonged Efficacy open‐Label (
                    <scp>COMPEL</scp>
                    ) trial},
  author = {Andrew M. Blumenfeld and Larry Charleston and Deena Kuruvilla and Belinda Savage‐Edwards and Richard B. Lipton and Ritu Singh and Patricia Jacob and Nicole A. Lawrence and Cuiwei Wang and Hope L. O'Brien},
  year = {2025},
  journal = {Headache: The Journal of Head and Face Pain},
  doi = {10.1111/head.70007},
  url = {https://doi.org/10.1111/head.70007}
}

RIS

TY  - JOUR
TI  - <scp>OnabotulinumtoxinA</scp>
                    treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine
                    <scp>OnabotulinuMtoxinA</scp>
                    Prolonged Efficacy open‐Label (
                    <scp>COMPEL</scp>
                    ) trial
AU  - Andrew M. Blumenfeld
AU  - Larry Charleston
AU  - Deena Kuruvilla
AU  - Belinda Savage‐Edwards
AU  - Richard B. Lipton
AU  - Ritu Singh
AU  - Patricia Jacob
AU  - Nicole A. Lawrence
AU  - Cuiwei Wang
AU  - Hope L. O'Brien
PY  - 2025
JO  - Headache: The Journal of Head and Face Pain
DO  - 10.1111/head.70007
UR  - https://doi.org/10.1111/head.70007
ER  -

APA

Blumenfeld, A. M., Charleston, L., Kuruvilla, D., Savage‐Edwards, B., Lipton, R. B., Singh, R., Jacob, P., Lawrence, N. A., Wang, C., & O'Brien, H. L. (2025). <scp>OnabotulinumtoxinA</scp> treatment among diverse racial groups: Post hoc analysis of the phase 4 Chronic migraine <scp>OnabotulinuMtoxinA</scp> Prolonged Efficacy open‐Label ( <scp>COMPEL</scp> ) trial. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.70007

Source records

crossref · retrieved 2026-09-25T13:36:17.438Z